Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) is a major cause of liver fibrosis/cirrhosis and liver-related mortality. Despite emergence of noninvasive tests, liver biopsy remains the mainstay for the diagnosis and assessment of disease severity and chronicity. Accurate...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wolters Kluwer Medknow Publications
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/86e35ff04b0b4afda29654ecb13f3e75 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|